Arvind Julius Trindade

Arvind Julius Trindade

Auto-generated profile, based on publicly available information

Arvind Julius Trindade

Division of Gastroenterology, Rutgers University School of Medicine, New Brunswick, United States

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2023 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
KSKelly Suchman
Kelly Suchman
SGShashank Garg
Shashank Garg
ATArvind J. Trindade
Arvind J. Trindade
INTRODUCTION: Chat Generative Pretrained Transformer (ChatGPT) is a natural language processing model that generates human-like text. METHODS: ChatGPT-3 and ChatGPT-4 were used to answer the 2022 and 2021 American College of Gastroenterology self-assessment tests. The exact questions were inputted in both versions of ChatGPT. A score of 70% or higher was required to pass the assessment. RESULTS: Overall, ChatGPT-3 scored 65.1% on 455 included questions and GPT-4 scored 62.4%. DISCUSSION: ChatGPT did not pass the American College of Gastroenterology self-assessment test. We do not recommend its use for medical education in gastroenterology in its current form.

1 December 2020 in Gastroenterology
Verified
Journal Article
Open access
PDF file
SISumant Inamdar
Sumant Inamdar
PBPetros C. Benias
Petros C. Benias
YLYan Liu
Yan Liu
DSDivyesh V. Sejpal
Divyesh V. Sejpal
SSSanjaya K. Satapathy
Sanjaya K. Satapathy
ATArvind J. Trindade
Arvind J. Trindade
This is a retrospective observational cohort study of patients 18 years or older admitted to 12 hospitals within the Northwell Health System from March 1, 2020, to June 1, 2020, during the COVID-19 pandemic in New York. Institutional review board approval was obtained for this study. Patients were identified as presenting with acute pancreatitis on admission if they met all 3 of the following criteria: 1) lipase level greater than 3 times the upper limit of normal, 2) cross-sectional imaging (computed tomography or magnetic resonance imaging) showing pancreatitis, and 3) characteristic upper abdominal pain at admission. Tenner S. et al. Am J Gastroenterol. 2013; 108 : 1400-1415 Crossref PubMed Scopus (895) Google Scholar Those with acute pancreatitis and COVID-19 were compared to a group of patients with acute pancreatitis but without COVID-19. Patient charts were manually reviewed not only to confirm the diagnosis of pancreatitis but also to determine its etiology (see the Supplementary Methods section for details). The primary outcomes of mortality, length of stay, need for mechanical ventilation, and development of pancreatic necrosis were compared between the 2 groups.

1 August 2020 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
KCKimberly Cavaliere
Kimberly Cavaliere
CLCalley Levine
Calley Levine
PWPraneet Wander
Praneet Wander
DSDivyesh V. Sejpal
Divyesh V. Sejpal
ATArvind J. Trindade
Arvind J. Trindade

1 January 2016 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
SISumant Inamdar
Sumant Inamdar
TBTyler M. Berzin
Tyler M. Berzin
DSDivyesh V. Sejpal
Divyesh V. Sejpal
DPDouglas K. Pleskow
Douglas K. Pleskow
RCRam Chuttani
Ram Chuttani
ATArvind J. Trindade
Arvind J. Trindade

6 September 2016 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
PDF file
SISumant Inamdar
Sumant Inamdar
DHDennis Han
Dennis Han
MPMonica Passi
Monica Passi
DSDivyesh V. Sejpal
Divyesh V. Sejpal
ATArvind J. Trindade
Arvind J. Trindade

20 December 2020 in Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
ATArvind Julius Trindade
Arvind Julius Trindade
SIStephanie Izard
Stephanie Izard
KCKevin Coppa
Kevin Coppa
JHJamie S. Hirsch
Jamie S. Hirsch
CLCalvin Lee
Calvin Lee
TCThe Northwell COVID‐19 Research Consortium
The Northwell COVID‐19 Research Consortium
Background and Aims: Gastrointestinal (GI) bleeding has been observed amongst patients hospitalized with COVID‐19. Recently, anticoagulation has shown to decrease mortality, but it is unclear whether this contributes to increased GI bleeding. The aims of this study are: (i) to examine whether there are risk factors for GI bleeding in COVID‐19 patients and (ii) to study whether there is a mortality difference between hospitalized patients with COVID‐19 with and without GI bleeding.Methods: This is a propensity score matched case–control study from a large health system in the New York metropolitan area between March 1st and April 27th. COVID‐19 patients with GI bleeding were matched 1:1 to COVID‐19 patients without bleeding using a propensity score that took into account comorbidities, demographics, GI bleeding risk factors and length of stay.Results: Of 11, 158 hospitalized with COVID‐19, 314 patients were identified with GI bleeding. The point prevalence of GI bleeding was 3%. There were no identifiable risk factors for GI bleeding. Use of anticoagulation medication or antiplatelet agents was not associated with increased risk of GI bleeding in COVID‐19 patients. For patients who developed a GI bleed during the hospitalization, there was an increased mortality risk in the GI bleeding group (OR 1.58, P = 0.02).Conclusion: Use of anticoagulation or antiplatelet agents was not risk factors for GI bleeding in a large cohort of hospitalized COVID‐19 patients. Those with GI bleeding during the hospitalization had increased mortality.